SCHEMBL7302636

SCHEMBL7302636

COc1ccc(-c2ccccc2S)cc1.Sc1ccc(-c2ccccc2Cl)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 1/20 0.46
▸ ABCB1 P08183 1/20 0.46
▸ BCR P11274 1/20 0.46
▸ CYP2A6 P11509 1/20 0.43
▸ HDAC4 P56524 1/20 0.42
▸ HDAC2 Q92769 1/20 0.42
▸ HDAC8 Q9BY41 1/20 0.42
▸ PTPN1 P18031 1/20 0.41
▸ HSP90AA1 P07900 1/20 0.41
▸ HSP90AB1 P08238 1/20 0.41
▸ MAPT P10636 4/20 0.40
▸ NPC1 O15118 2/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ TP53 P04637 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ BACE1 P56817 2/20 0.39
▸ NFE2L2 Q16236 2/20 0.39
▸ RELA Q04206 1/20 0.39
▸ APP P05067 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7278655 0.85 ABL1 (0.60) ABL1ABCB1BCRHDAC4HDAC2
SCHEMBL5681041 0.85 ABL1 (0.60) ABL1ABCB1BCRCYP2A6HDAC4
SCHEMBL7302639 0.84 ABL1 (0.51) ABL1ABCB1BCRHDAC4HDAC2
SCHEMBL11295417 0.80 CYP2A6 (0.65) CYP2A6NPC1RAB9ASMN1; SMN2TP53
SCHEMBL22931425 0.76 IDO1 (0.38) ABL1ABCB1BCRCYP2A6HDAC8
SCHEMBL31345281 0.74 HSP90AA1 (0.44) ABL1ABCB1BCRCYP2A6HDAC4
SCHEMBL7243101 0.72 ESR2 (0.58) ABL1ABCB1BCRHDAC4HDAC2
SCHEMBL12715050 0.72 ABL1 (0.79) ABL1ABCB1BCRHDAC4HDAC2
SCHEMBL28841013 0.71 GSTP1 (0.59) ABL1ABCB1BCRCYP2A6NPC1
SCHEMBL31345280 0.71 GPR3 (0.45) ABL1ABCB1BCRCYP2A6PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0550111-B1 2-Saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and pharmaceutical compositions containing them SANOFI SA (FR) 1999-04-14 — — EP disclosed
EP-0550111-A1 2-Saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and pharmaceutical compositions containing them STERLING WINTHROP INC. (US) 1993-07-07 — — EP disclosed
Send feedback